Goto J, Miura H, Ando M, Nambara T, Makino I
Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1960-2. doi: 10.1248/cpb.37.1960.
7 alpha,12 alpha-Dihydroxy-3-oxo-5 beta-cholanoic acid labeled with 18O atoms was incubated with human blood, and the biotransformation products were separated and characterized by gas chromatography-mass spectrometry as the pentafluorobenzyl ester-trimethylsilyl and -dimethylethylsilyl ether derivatives. 3 beta,7 alpha,12 alpha-Trihydroxy-5 beta-cholanoic acid was identified as a main metabolite. When 3-oxo bile acid was incubated with human blood denatured at 70 degrees C for 2 min, no metabolites were formed. The enzymic reduction activity proved to be localized in the red blood cell fraction.
将用(^{18}O)原子标记的(7α,12α - 二羟基 - 3 - 氧代 - 5β - 胆烷酸与人血一起孵育,生物转化产物通过气相色谱 - 质谱法分离并表征为五氟苄基酯 - 三甲基甲硅烷基和 - 二甲基乙基甲硅烷基醚衍生物。(3β,7α,12α - 三羟基 - 5β - 胆烷酸被鉴定为主要代谢物。当将3 - 氧代胆汁酸与在(70℃)变性(2)分钟的人血一起孵育时,未形成代谢物。酶促还原活性被证明定位于红细胞部分。